M., L., N., N., G., J., P., T., T.R., C., I.J., C., . . . S., K. (2014). Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
Chicago Style CitationM., Lallemant, et al. Efficacy and Safety of 1-month Postpartum Zidovudine-didanosine to Prevent HIV-resistance Mutations After Intrapartum Single-dose Nevirapine. 2014.
MLA CitationM., Lallemant, et al. Efficacy and Safety of 1-month Postpartum Zidovudine-didanosine to Prevent HIV-resistance Mutations After Intrapartum Single-dose Nevirapine. 2014.
Warning: These citations may not always be 100% accurate.